SCOTUS Denies MD Law Aimed at Generic Drug Prices

The U.S. Supreme Court has declined to review a federal court's decision that struck down a unique Maryland law to curb price gouging for generic prescription drugs. The General Assembly passed the law in 2017 at the urging of state Attorney General Brian Frosh and health care advocates.